Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|November 13, 2013
The lack of predictors for rapid progression in prostate cancer patients receiving sipuleucel-TLaura Ng, Wendy Heck, Stacey Lavsa, et al.
Sleep Science (Sao Paulo, Brazil)|February 13, 2019
A nonparametric methodological analysis of rest-activity rhythm in type 2 diabetesPaula Cavalcanti-Ferreira, Lee Berk, Noha Daher, et al.
Plos One|December 22, 2020
A science impact framework to measure impact beyond journal metricsMary D Ari, John Iskander, John Araujo, et al.
Clinical Genitourinary Cancer|November 12, 2024
Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell TumorsJenny J Xiang, Matthew T Campbell, Shi-Ming Tu, et al.
European Urology Oncology|August 15, 2019
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer PatientsEleni Efstathiou, Mark Titus, Sijin Wen, et al.
International Journal of Cancer|March 19, 2021
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experienceOmar Alhalabi, Elshad Hasanov, Nathaniel R Wilson, et al.
European Urology|July 10, 2012
A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinomaNizar M Tannir, Elizabeth Plimack, Chaan Ng, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancerNicholas Spetsieris, Myrto Boukovala, Ioannis Alafis, et al.
Arquivos De Neuro-Psiquiatria|August 24, 2010
New guidelines for diagnosis and treatment of insomniaLuciano Ribeiro Pinto, Rosana Cardoso Alves, Eliazor Caixeta, et al.
Oncogene|September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelEstefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
Pageof 3